European Journal of Molecular & Clinical Medicine

Abstract

Background:
Pulmonary Hypertension (PH) is a diversified group of entities affecting the pulmonary
vasculature. Early detection is pivotal in the appropriate treatment of pulmonary hypertension.
The initial and the simplest step in the detection of pulmonary hypertension is the performance
of a combination of chest radiography, transthoracic Doppler echocardiography, and ECG.
Methodology:
An extensive literature review on the role of radiology and clinical medicine in pulmonary
hypertension complication.
Results:
The study showed that Computed Tomography (CT) was the best imaging modality in the
determination of the early onset of PH. Multiple clinical medicines like epoprostenol, nitric
oxide, iloprost, and imatinib have been used to enhance and improve the exercise capacity,
cardiac output, and hemodynamic function of the patient suffering from PH.
Conclusion:
No meaningful decrease in the time from the onset of symptoms to the PH diagnosis has been
achieved in the last 20 years. However, multiple detection methods, such as the introduction of
radiology and the use of texture-based lung graph models, have been slowly bridging this gap.
Newer techniques in radiology will help in early detection of the disease and thus help in
controlling it.